View by Specialty

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

Adrenal News

SPONSORED CONTENT
Save
SPONSORED CONTENT
June 19, 2023
3 min read
Save

Adults diagnosed with adrenocortical cancer have 54% overall survival at 5 years

Adults diagnosed with adrenocortical cancer have 54% overall survival at 5 years

Adults who are diagnosed with adrenocortical cancer have a 5-year overall survival of 54%, with overall survival higher among those with stage I or stage II cancer, according to study findings.

SPONSORED CONTENT
June 15, 2023
6 min read
Save

A coming ‘renaissance in endocrinology’: A conversation with R. Scott Struthers, PhD

A coming ‘renaissance in endocrinology’: A conversation with R. Scott Struthers, PhD

R. Scott Struthers, PhD, had a lab job synthesizing peptide hormones as a college freshman. That experience launched a career featuring discovery of novel agents for endocrine diseases, women’s health conditions and cancers.

Trending

PC0924Houry_Graphic_01_WEB
September 11, 2024
4 min read
Save

CDC data reveal three social drivers that influence suicide risk

SPONSORED CONTENT
June 15, 2023
4 min read
Save

Climate change, aging among topics to be highlighted at ENDO 2023

Climate change, aging among topics to be highlighted at ENDO 2023

Experts from across the field of endocrinology will converge on Chicago beginning Thursday for the 2023 Endocrine Society annual meeting.

SPONSORED CONTENT
June 02, 2023
8 min watch
Save

VIDEO: Pituitary and adrenal research highlights from ECE 23

VIDEO: Pituitary and adrenal research highlights from ECE 23

In this video exclusive, Maria Fleseriu, MD, FACE, reviews the pituitary and adrenal research highlights presented at ECE 2023, the annual meeting of the European Society of Endocrinology, which took place in Istanbul, Turkey, in May.

SPONSORED CONTENT
May 16, 2023
6 min watch
Save

VIDEO: Screening a key part of treatment for primary hyperaldosteronism

VIDEO: Screening a key part of treatment for primary hyperaldosteronism

In this video exclusive, Jonathan D. Leffert, MD, talks with Richard J. Auchus, MD, PhD, FACE, about how to define primary hyperaldosteronism, the importance of screening and tips for treating the disease.

SPONSORED CONTENT
May 15, 2023
5 min read
Save

Addressing glucocorticoid withdrawal syndrome in treatment of Cushing’s syndrome

Addressing glucocorticoid withdrawal syndrome in treatment of Cushing’s syndrome

To achieve optimal outcomes in Cushing’s syndrome, both clinicians and patients need to be prepared for the type and duration of symptoms that patients may experience during treatment and recovery.

SPONSORED CONTENT
May 06, 2023
2 min read
Save

High post-dexamethasone cortisol levels linked to lower eGFR independent of CV factors

High post-dexamethasone cortisol levels linked to lower eGFR independent of CV factors

SEATTLE — Higher post-dexamethasone cortisol was associated with lower estimated glomerular filtration rate independent of cardiovascular risk factors, researchers reported at the AACE Annual Scientific and Clinical Conference.

SPONSORED CONTENT
February 06, 2023
3 min read
Save

Oral contraceptive use may cause false-positive test for primary aldosteronism

Oral contraceptive use may cause false-positive test for primary aldosteronism

Women who use oral contraceptives are more likely to have an aldosterone-to-renin ratio above the threshold for a positive test for primary aldosteronism than those who do not use oral contraceptives, according to study data.

SPONSORED CONTENT
September 19, 2022
2 min read
Save

Prescribed hydrocortisone dose shrinks with weight gain in congenital adrenal hyperplasia

Prescribed hydrocortisone dose shrinks with weight gain in congenital adrenal hyperplasia

Clinicians are prescribing children with congenital adrenal hyperplasia decreasing dosages of hydrocortisone per body surface area as weight and BMI increase, without worse treatment outcomes, according to study data.

SPONSORED CONTENT
September 14, 2022
2 min read
Save

Lower costs with ambulatory fludrocortisone suppression test vs. in-patient testing

Lower costs with ambulatory fludrocortisone suppression test vs. in-patient testing

Ambulatory fludrocortisone suppression testing for primary aldosteronism has similar accuracy compared with in-patient fludrocortisone suppression testing but with significantly lower health care costs, according to study data.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails